Dermatophytic Onychomycosis Market

Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis.
Dermatophytic Onychomycosis Market aims to provide a comprehensive presentation of the global market for Dermatophytic Onychomycosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatophytic Onychomycosis. Dermatophytic Onychomycosis Market contains market size and forecasts of Dermatophytic Onychomycosis in global, including the following market information:
Global Dermatophytic Onychomycosis Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Dermatophytic Onychomycosis market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Factors such as the rising prevalence of dermatophytic onychomycosis, heavy investments to develop therapies, and frequent product innovations will aid in the steady growth of this market during the forecast period. An important factor that will impel the prospects for growth in this market is the augmented focus on combination therapies. Recently, it has been observed that a combination of topical and systemic treatment increases the cure rate when compared to individual therapies. Since combination therapies have improved clinical efficiency and are more cost-effective than terbinafine, they are increasingly being preferred over individual terbinafine-based therapies as they have a higher cure rate.
We surveyed the Dermatophytic Onychomycosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dermatophytic Onychomycosis Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Dermatophytic Onychomycosis Market Segment Percentages, by Type, 2022 (%)
Oral Medicine
External Medicine
Global Dermatophytic Onychomycosis Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Dermatophytic Onychomycosis Market Segment Percentages, by Application, 2022 (%)
Age Under 18
Age 18-50
Age Above 50
Global Dermatophytic Onychomycosis Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Dermatophytic Onychomycosis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dermatophytic Onychomycosis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Dermatophytic Onychomycosis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
GSK
Novartis
Pfizer
Bausch Health
Kaken Pharmaceutical
Galderma
Sanofi
Allergan
Merz Pharma
Xiuzheng Pharmaceutical
Letai
Qilu Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dermatophytic Onychomycosis, market overview.
Chapter 2: Global Dermatophytic Onychomycosis market size in revenue.
Chapter 3: Detailed analysis of Dermatophytic Onychomycosis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dermatophytic Onychomycosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.